fbpx

Diagnostyka Sp. z o.o., a provider of medical laboratory services, and Polski Bank Komórek Macierzystych have executed an agreement pursuant to which PBKM has acquired a 100% stake in Diagnostyka Bank Komórek Macierzystych Sp. z o.o. (which, until now, had Diagnostyka Sp. z o. o. as its majority shareholder) while Diagnostyka acquired a small stake in PBKM. The goals of this transaction include expansion of PBKM’s offer beyond services associated strictly with stem cells, development of new products and services by DIAGNOSTYKA, and benefiting from the synergies generated by PBKM and DIAGNOSTYKA between them to reach new customers.

GESSEL provided comprehensive legal services for the transaction on the PBKM side, including a due diligence study and drafting and negotiation of the investment agreement regulating the entire transaction.

The GESSEL lawyers involved in this project included Maciej Kożuchowski – managing associate, Barbara Łągiewka – trainee attorney, Magdalena Szeplik – trainee advocate, and Bartłomiej Woźniak – trainee advocate.